BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4010890)

  • 1. Intravertebral angiotensin II inhibits cardiac vagal efferent activity in dogs.
    Potter EK; Reid IA
    Neuroendocrinology; 1985 Jun; 40(6):493-6. PubMed ID: 4010890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the vagal component of the baroreceptor-cardioinhibitory reflex by angiotensin III in dogs and sheep.
    Lumbers ER; Potter EK
    J Physiol; 1983 Mar; 336():83-9. PubMed ID: 6875923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog.
    Lumbers ER; McCloskey DI; Potter EK
    J Physiol; 1979 Sep; 294():69-80. PubMed ID: 512963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cardiovascular effects of intravertebral angiotensin II before and after treatment with clonidine.
    Lumbers ER; Reid IA
    Clin Exp Pharmacol Physiol; 1981; 8(5):531-5. PubMed ID: 7326876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Droperidol inhibits cardiac vagal efferents in dogs.
    Nashan B; Inoue K; Arndt JO
    Br J Anaesth; 1984 Nov; 56(11):1259-66. PubMed ID: 6487445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravertebral angiotensin II on cardiac output and its distribution in conscious dogs.
    Quillen EW; Reid IA
    Circ Res; 1988 Oct; 63(4):702-11. PubMed ID: 3168175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitation of the cardiac vagus by vasopressin in mammals.
    Courtice GP; Kwong TE; Lumbers ER; Potter EK
    J Physiol; 1984 Sep; 354():547-56. PubMed ID: 6481644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrial receptor inhibition of cardiac efferent vagal activity in the dog.
    Chapman LW; Mittman U; Prickett C; Richmond W
    Clin Exp Pharmacol Physiol; 1978; 5(5):471-6. PubMed ID: 729206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D-Met2,Pro5]enkephalinamide activates cardioinhibitory efferents in anaesthetized dogs.
    Inoue K; Nashan B; Arndt JO
    Eur J Pharmacol; 1985 Apr; 110(2):233-9. PubMed ID: 3921390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of vasoactive peptides on the carotid cardiac baroreflex.
    Lumbers ER; Potter EK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():45-9. PubMed ID: 6958400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the actions of angiotensin on the central nervous system of conscious dogs.
    Reid IA; Brooks VL; Rudolph CD; Keil LC
    Am J Physiol; 1982 Jul; 243(1):R82-91. PubMed ID: 6283922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efferent pathways of the cardiovascular response to vertebral artery infusions of angiotensin in the dog.
    Scroop GC; Lowe RD
    Clin Sci; 1969 Dec; 37(3):605-19. PubMed ID: 4312146
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of blockade of brain angiotensin II receptors in conscious, sodium-deprived dogs.
    Brooks VL; Reid IA
    Am J Physiol; 1983 Dec; 245(6):R881-7. PubMed ID: 6318577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of withdrawal of efferent cervical vagal stimulation on anesthetized dogs--relative importance of chronotropic and non-chronotropic mechanisms.
    Cevese A; Verlato G
    J Auton Nerv Syst; 1985 Oct; 14(2):125-36. PubMed ID: 4067179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of baroreceptor denervation on stimulation of drinking by angiotensin II in conscious dogs.
    Klingbeil CK; Brooks VL; Quillen EW; Reid IA
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E333-7. PubMed ID: 2003587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of intravenous infusion on heart rate, sympathetic and vagal efferentation and left atrial and aortic baroreceptor activity in dogs.
    Hakumäki MO
    Acta Physiol Scand; 1979 Oct; 107(2):127-33. PubMed ID: 525375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin inhibits action of vagus nerve at the heart.
    Potter EK
    Br J Pharmacol; 1982 Jan; 75(1):9-11. PubMed ID: 7074289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heart as a biological clock: phase-locking between heart and efferent vagal activity.
    Schena F; Poltronieri R; Verlato G; Cevese A
    Funct Neurol; 1990; 5(3):247-9. PubMed ID: 2283097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the action of angiotensin II on the baroreflex control of heart rate in conscious rabbits.
    Reid IA; Chou L
    Endocrinology; 1990 May; 126(5):2749-56. PubMed ID: 2328705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of diterpenoid alkaloids on cardiac sympathetic efferent and vagal afferent nerve activity.
    Chiao H; Pelletier SW; Desai HK; Rebagay WR; Caldwell RW
    Eur J Pharmacol; 1995 Sep; 283(1-3):103-6. PubMed ID: 7498298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.